An Intrapericardial Injectable Hydrogel Patch for Mechanical-Electrical Coupling with Infarcted Myocardium

ACS Nano. 2022 Oct 25;16(10):16234-16248. doi: 10.1021/acsnano.2c05168. Epub 2022 Oct 3.


Although hydrogel-based patches have shown promising therapeutic efficacy in myocardial infarction (MI), synergistic mechanical, electrical, and biological cues are required to restore cardiac electrical conduction and diastolic-systolic function. Here, an injectable mechanical-electrical coupling hydrogel patch (MEHP) is developed via dynamic covalent/noncovalent cross-linking, appropriate for cell encapsulation and minimally invasive implantation into the pericardial cavity. Pericardial fixation and hydrogel self-adhesiveness properties enable the MEHP to highly compliant interfacial coupling with cyclically deformed myocardium. The self-adaptive MEHP inhibits ventricular dilation while assisting cardiac pulsatile function. The MEHP with the electrical conductivity and sensitivity to match myocardial tissue improves electrical connectivity between healthy and infarcted areas and increases electrical conduction velocity and synchronization. Overall, the MEHP combined with cell therapy effectively prevents ventricular fibrosis and remodeling, promotes neovascularization, and restores electrical propagation and synchronized pulsation, facilitating the clinical translation of cardiac tissue engineering.

Keywords: conducting polymer; injectable hydrogel; mechanical−electrical coupling; myocardial repair; tissue engineering.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Electric Conductivity
  • Humans
  • Hydrogel, Polyethylene Glycol Dimethacrylate / pharmacology
  • Hydrogels* / pharmacology
  • Hydrogels* / therapeutic use
  • Myocardial Infarction* / drug therapy
  • Myocardium


  • Hydrogels
  • mono-(2-ethylhexyl)phthalate
  • Hydrogel, Polyethylene Glycol Dimethacrylate